Key result
Targeted recruitment of PKA to the E1 subunit reconstituted physiological IKs enhancement, whereas recruitment to Q1 constitutively inhibited IKs by retaining the channel intracellularly.
Why the study?
Mutations in Q1 or AKAP9 disrupting PKA regulation of I Ks cause long QT syndrome and increase sudden cardiac death risk during exercise, prompting investigation into a targeted protein phosphorylation approach to reconstitute PKA regulation without AKAP9.
The functional outcome of synthetically recruited PKA on IKs regulation depends critically on the site of recruitment within the channel complex, suggesting a potential targeted protein phosphorylation approach for long QT syndrome.
No takes yet. Share an insight, caveat, or question.
Site-specific PKA effects on IKs may guide LQTS strategies; leaves open targeted phosphorylation approaches pending human validation.
Zou et al. (2023) studied Long QT syndrome type 1 and 11. Targeted protein phosphorylation (TPP) using nanobody-mediated PKA recruitment vs. Free Cα or absence of AKAP9 was evaluated on IKs regulation, channel complex localization, and phosphorylation. Targeted recruitment of PKA to the E1 subunit reconstituted physiological IKs enhancement, whereas recruitment to Q1 constitutively inhibited IKs by retaining the channel intracellularly.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: